Pacer Advisors’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-4,017
| Closed | -$321K | – | 1614 |
|
|
2021
Q1 | $321K | Sell |
4,017
-110
| -3% | -$8.59K | 0.01% | 1209 |
|
|
2020
Q4 | $325K | Sell |
4,127
-4,802
| -54% | -$282K | 0.01% | 1133 |
|
|
2020
Q3 | $392K | Buy |
+8,929
| New | +$440K | 0.01% | 1060 |
|
|
2020
Q1 | – | Sell |
-12,495
| Closed | -$886K | – | 1208 |
|
|
2019
Q4 | $886K | Sell |
12,495
-930
| -7% | -$67.5K | 0.04% | 601 |
|
|
2019
Q3 | $1M | Sell |
13,425
-1,021
| -7% | -$86.5K | 0.02% | 825 |
|
|
2019
Q2 | $1.17M | Buy |
+14,446
| New | +$1.02M | 0.03% | 749 |
|
|
2018
Q4 | – | Sell |
-13,134
| Closed | -$1.21M | – | 1136 |
|
|
2018
Q3 | $1.21M | Buy |
13,134
+2,057
| +19% | +$196K | 0.05% | 568 |
|
|
2018
Q2 | $1.09M | Buy |
11,077
+1,184
| +12% | +$132K | 0.05% | 578 |
|
|
2018
Q1 | $1.1M | Buy |
+9,893
| New | +$1.11M | 0.06% | 423 |
|
|
2017
Q4 | – | Sell |
-4,603
| Closed | -$433K | – | 1354 |
|
|
2017
Q3 | $433K | Buy |
4,603
+475
| +12% | +$37.5K | 0.04% | 751 |
|
|
2017
Q2 | $322K | Buy |
4,128
+437
| +12% | +$32.8K | 0.03% | 820 |
|
|
2017
Q1 | $296K | Buy |
3,691
+665
| +22% | +$52.8K | 0.04% | 759 |
|
|
2016
Q4 | $238K | Buy |
3,026
+129
| +4% | +$10K | 0.03% | 796 |
|
|
2016
Q3 | $226K | Buy |
+2,897
| New | +$210K | 0.03% | 758 |
|
Pacer Advisors's CMD Position: Q2 2021 in Review
Pacer Advisors sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 4,017 shares — an estimated $321K sold.
Pacer Advisors first reported a position in CMD in Q3 2016 and held it in 14 quarters. The position peaked at $1.21M in Q3 2018. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Pacer Advisors reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Pacer Advisors sold 4,017 Cantel Medical Corporation shares in Q2 2021, an estimated $321K.
- Pacer Advisors first reported a position in Cantel Medical Corporation in Q3 2016 and held it in 14 quarters.
- Pacer Advisors's Cantel Medical Corporation position peaked at $1.21M in Q3 2018.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Pacer Advisors's 13F filing for Q2 2021, filed 21 Jul 2021.